Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib.
AUTOR(ES)
Boyer, K M
RESUMO
We studied the concentration of circulating human immunoglobulin G (IgG) antibody to the native capsular polysaccharide of group B streptococcus (GBS) type Ib necessary to protect mice against lethal challenge by laboratory and clinical GBS Ib strains. Antibody was measured by an enzyme-linked immunosorbent assay in which native polysaccharide antigen coupled to human serum albumin was used. The assay was standardized by a quantitative precipitation test, using native antigen and specific human IgG antibody purified by affinity chromatography. IgG anti-GBS Ib antibody level-protection curves for 90% lethal dose challenge of mice were sigmoidal. The curves of whole serum and affinity-chromatographed IgG anti-GBS Ib were superimposable. The serum concentrations of human antibody required for complete protection of mice varied with the infecting strain and ranged from 0.038 to 0.175 microgram/ml. Protective levels of human IgG anti-GBS Ib were lower than those we found previously for homologous protection against GBS Ia challenge (range, 0.25 to 1.0 microgram/ml).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=263339Documentos Relacionados
- Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.
- Measurement of Human Antibodies to Type III Group B Streptococcus
- Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.
- Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides.
- Nonimmune binding of human immunoglobulin A to type II group B streptococci.
